FDA Inspection
Davion IncDavion Inc – FDA Inspection, Nov 19, 2009
Record Details
This FDA Inspection record concerns Davion Inc, with an inspection on November 19, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Davion Inc
- Inspection Date
- November 19, 2009
- Product Type
- Drugs
View Company Profile
ID · d2ea5a45-8117-4c4d-91c8-69dc86807dd3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 628648
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
5- 21 CFR 211.188Prepared for each batch, include complete information
- 21 CFR 211.25(a)Training--operations, GMPs, written procedures
- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.150Written distribution procedure
- 21 CFR 211.100(a)Approval and review of procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Davion Inc
4| Date | Classification | Office | Project area |
|---|---|---|---|
| January 24, 2025 | VAI | New Jersey District Office | Drug Quality Assurance |
| May 15, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 22, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 10, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Davion Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.